In recent years, pleurotin has become the center of attention as a potential new anti-cancer lead drug for its highly effective inhibition of the thioredoxin (Trx)–thioredoxin reductase (TrxR) system [10], a favorable target in the treatment of cancer as well as mercury intoxication [11]. The gene discussed is TXN; the disease is cancer.